commercialization

Dialytics, Inc. is a marine-oriented research, development, and commercialization company focused on renewable water-food-energy nexus solutions. It works on Salinity Gradient Power (SGP) energy generation, microalgal/diatom aquaculture for feeds, foods, nutraceuticals, and bioproducts, and marine bio-waste reduction, reuse, and utilization including biodegradable chitin/chitosan gels and membranes and biogenic silica. It is a member of the University of South Florida CONNECT Tampa Bay Technology Incubator.

chitin extractionmembrane-based energy generationmicroalgal/diatom aquacultureresearch and development

ECHELON Med Tech develops and commercializes dual-use medical technologies to improve health outcomes for warfighters, veterans and civilians. The company partners with medical device research innovators to create solutions for health problems faced on the battlefield and on Main Street, using a proprietary technology assessment model to evaluate market need, IP strength, grant history and other criteria.

FDA clearancehypothesis testingmanufacturing scale-upproof of concept developmenttechnology assessmentVoice of Customer research

Edible Chemistry Consulting is a Jacksonville, Florida-based, certified Woman Owned Business with over 65 years of combined expertise in product development and commercialization for the food, beverage, and dietary supplement industries. It helps companies of all sizes develop scientific processes to solve problems during development, scale up, and commercialization of beverage, dairy, supplement, and food products.

ingredient sourcingon-site technical servicesprocess optimizationproduct developmentproduct scalingprototypingregulatory and quality compliancetraining

Equity Space Alliance is a self-certified Economically Disadvantaged Woman-Owned Small Business (EDWOSB) founded by industry professionals with backgrounds including NASA missions, tech startups, and strategic advisory roles. It provides end-to-end solutions for the space industry, including consortium management for space technology R&D at HBCUs, engineering and technical solutions, technology transfer and commercialization, business strategy consulting, and workforce development and talent acquisition.

business strategy consultingconsortium managementengineering and technical solutionssupplier developmenttalent acquisitiontechnology transferworkforce development

Eton Pharmaceuticals is an innovative pharmaceutical company that searches the world over for meaningful therapies to bring to patients living with rare diseases. It discovers and develops therapies for small patient populations, sourcing potential therapies worldwide and navigating the drug development and FDA approval process to bring promising therapies to market. The company has brought multiple approvals to market in just 4 years, with more in the pipeline.

clinical trialsdrug discovery and developmentFDA approval navigationsourcing therapies worldwide

Fathom Solutions is a Service-Disabled Veteran-Owned Small Business (SDVOSB) strategy and advisory firm supporting mission-driven healthcare and government innovators. It partners with healthcare innovators, government agencies, and technology companies to accelerate growth, secure federal contracts, and deliver operational excellence, bringing decades of leadership experience across healthcare technology, federal contracting, and operational execution.

Federal procurement & contractinggo-to-market strategyGrowth StrategyMarket Accessstrategic partnerships

Fimbrion Therapeutics, Inc. is a St. Louis-based company whose mission is to discover, develop, and commercialize antimicrobial-sparing and -enabling drugs for the prevention and treatment of infectious diseases caused by bacteria, including drug-resistant strains. Its initial focus is an orally active drug to prevent and treat urinary tract infections (UTIs), targeting bacterial adhesins rather than bacterial viability.

drug developmentdrug discovery

Four Corner Foods LLC offers innovative solutions to the food and beverage industry, with expertise ranging from new product development, manufacturing and process efficiency to microbiological reduction, quality control and food safety. It helps startups and large manufacturers commercialize products through product formulation, process development, QA and food safety programs. Principal Officer Abizer Khairullah has over 35 years in the industry.

engineering design and fabricationmanufacturingprocess development and optimizationproduct developmentQA and food safety programssensory analysis and trainingshelf life analysis

FTL Labs Corporation engineers and develops transitional technology, advancing highly marketable applied science from academia to the marketplace. Its team of academic scientists, industry engineers, and test and fabrication experts takes projects from concept to completion through research, engineering, management, planning, testing, execution, productization, and commercialization.

3D CAD and modelingautomated testing hardware designelectronics integrationengineeringexecutionfabricationManagementmil-spec testingPlanningproductizationresearchtesting

G&L Scientific is an Integrated Product Development and Market Access platform serving the pharmaceutical, biopharmaceutical, and biotechnology industries. Established in 1998, it provides specialist Regulatory Affairs and Quality Assurance services across 100+ global markets, spanning drug and clinical development, regulatory submissions, product approval, market access, quality and compliance, and business transformation. It offers a flexible Functional Service Provider (FSP) model and won the Queen's Award for Enterprise 2022 and King's Award for Ente

Advisory, Transformation and Designclinical developmentCMC servicesFull Service OutsourcingFunctional Service Provider modelMarket Accessquality assuranceRegulatory AffairsStaff augmentation

GreenLight Biosciences is a public benefit corporation (PBC) that develops RNA-based solutions for agriculture and other applications. Its proprietary platform creates high-quality, affordable RNA at scale. Its plant health pipeline includes insecticides, fungicides, and herbicides, including Calantha, which is US EPA approved for control of Colorado Potato Beetles in potato crops, and Norroa, an RNA-based treatment for Varroa mites.

research and developmentRNA-based crop protectionRNA production platform

Helsinn is a global pharmaceutical company focused on supportive care, oncology and dermato-oncology, building, manufacturing, launching and commercializing products to improve the quality of life for patients with cancer and chronic diseases. Headquartered in Lugano, Switzerland, it has direct commercial operations in the U.S., manufacturing operations in Ireland, offices in China and partners enabling a commercial presence in 90 countries. Founded in 1976, it is a third-generation family-owned company.

developmentdirect salesin-licensinglife-cycle developmentmanufacturingout-licensingRegulatory Affairssupply chain

of page Unlocking The True Potential Of The World's Therapeutics Learn more about our groundbreaking technology COLLABORATE WITH US What we do Our research ABOUT US LEARN MORE Our Technology PIPELINE ABOUT USHera Health Solutions is a biotechnology company specializing in the research, development, and commercialization of a proprietary nanotechnology-enabled platform for transforming existing therapeutics into more effective and long-acting therapies.LATEST NEWSHera Health Solutions Technology Featured on Entrepreneur Magazine READ ARTICLE READ ARTICLE Newest Contract Partnership in 2025 Highlighted in Business Journal READ ARTICLE Hera Health Solutions Global Pharmaceutical Contract Announcement PROPRIETARY NANOTECHNOLOGY ENABLES THE RAPID REFORMULATION OF EXISTING APIs Pioneering the Future of Drug Delivery Upgraded and Customizable Release Profiles FDA & GMP-Approved Manufacturing &.

developmentdrug deliveryFDA & GMP-approved manufacturingreformulation of APIsresearch

Established in 2001, HexaTech, Inc. is a world leader in the development and commercialization of aluminum nitride (AlN), a wide bandgap semiconductor material. HexaTech has developed a proprietary crystal growth process yielding single crystalline AlN boules used to fabricate AlN substrates and wafers for III-nitride devices. In March 2020, Stanley Electric Co., Ltd. acquired HexaTech, which now operates as a Stanley Electric Group company.

crystal growthsemiconductor material developmentsubstrate fabrication

Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. Guided by science and collective expertise, it works closely with patients to understand real-world challenges and develop meaningful solutions. Its therapies include ARIKAYCE and BRINSUPRI, and its areas of innovation include gene therapy with targeted delivery, protein deimmunization, RNA end-joining, and synthetic rescue.

clinical trialsdrug developmentgene therapy with targeted deliveryprotein deimmunizationresearchRNA end-joiningsynthetic rescue

Insolcorp is a global industry leader in Phase Change Materials and the leading manufacturer and developer of inorganic PCMs in North America, based in Albemarle, North Carolina. The company specializes in the development, testing and commercialization of PCMs, focusing core technologies in life sciences and thermal storage industries to provide efficiency, resiliency and comfort to systems worldwide.

custom packaging solutionsdevelopment of phase change materialstestingthermal energy storage

ITF Therapeutics LLC is the United States rare disease affiliate of Italfarmaco S.p.A., established in January 2024 with headquarters in Concord, MA, to develop and commercialize rare disease treatments in the United States. It secured FDA approval for its first product within six months of launch and reached well over a thousand US patients with commercial supply by its first anniversary.

patient advocacy and engagementrare disease treatment development

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a biopharmaceutical company dedicated to developing life-changing medicines for people with rare diseases, often with limited or no therapeutic options. It has a diverse portfolio of marketed medicines including leading therapies addressing rare epilepsies, cancers and sleep disorders, and pursues research and development across a pipeline of innovative therapeutics. Corporate headquarters are in Dublin, Ireland, with offices in North America and Europe.

clinical developmentmanufacturingresearch and development

Jubilant Radiopharma is a global pharmaceutical company specializing in nuclear medicine, focused on developing, manufacturing, commercializing and distributing diagnostic and therapeutic radiopharmaceuticals. It combines the clinical expertise of a global manufacturer with a leading radiopharmacy network in the United States, serving millions of patients every year. A Jubilant Pharmova Company.

distributionmanufacturingradiopharmaceutical developmentresearch and drug development

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel cancer therapies. Its core technology leverages inhibition of nuclear export (XPO1 inhibition) and it describes itself as the industry leader in oral Selective Inhibitor of Nuclear Export (SINE) technology.

drug developmentdrug discoverySINE technologyXPO1 inhibition